×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [1]
INSTITUTE OF COL... [1]
Authors
XIANG YUTAO [1]
IP CHENG TENG [1]
Document Type
Journal article [2]
Date Issued
2024 [1]
2016 [1]
Language
英語English [2]
Source Publication
European Neurops... [1]
Psychological Me... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-2 of 2
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm study
Journal article
Jensen, Kristian H.Reveles, Urdanibia-Centelles, Olalla, Dam, Vibeke H., Köhler-Forsberg, Kristin, Frokjaer, Vibe G., Knudsen, Gitte M., Jørgensen, Martin B., Ip, Cheng T.. EEG abnormalities are not associated with poor antidepressant treatment outcome - A NeuroPharm study[J]. European Neuropsychopharmacology, 2024, 79, 59-65.
Authors:
Jensen, Kristian H.Reveles
;
Urdanibia-Centelles, Olalla
;
Dam, Vibeke H.
;
Köhler-Forsberg, Kristin
;
Frokjaer, Vibe G.
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
6.1
/
5.3
|
Submit date:2024/02/22
Eeg
Escitalopram
Major Depressive Disorder
Ssri
Verbal Memory
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study
Journal article
Hu Y.-D., Xiang Y.-T., Fang J.-X., Zu S., Sha S., Shi H., Ungvari G.S., Correll C.U., Chiu H.F.K., Xue Y., Tian T.-F., Wu A.-S., Ma X., Wang G.. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: Results from a randomized, placebo-controlled 4-week study[J]. Psychological Medicine, 2016, 46(3), 623.
Authors:
Hu Y.-D.
;
Xiang Y.-T.
;
Fang J.-X.
;
Zu S.
;
Sha S.
; et al.
Favorite
|
TC[WOS]:
109
TC[Scopus]:
117
|
Submit date:2018/10/30
Escitalopram
Ketamine
Key Words Efficacy
Major Depression
Response
Tolerability